KKR Genetic Disorder L.P.

Insider Reports History

Location
C/O Kohlberg Kravis Roberts & Co. L.P., 9 West 57 Th Street, Suite 4200, New York, NY
Signature
See Exhibit 99.1
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by KKR Genetic Disorder L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Pharma, Inc. 10%+ Owner Common Stock 13.3M $454M $34.20 May 12, 2025 Indirect

Insider Reports Filed by KKR Genetic Disorder L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BBIO BridgeBio Pharma, Inc. May 12, 2025 1 -$205M 4 May 14, 2025 10%+ Owner
BBIO BridgeBio Pharma, Inc. Mar 5, 2025 1 -$198M 4 Mar 7, 2025 10%+ Owner
BBIO BridgeBio Pharma, Inc. Sep 13, 2024 1 -$149M 4 Sep 17, 2024 10%+ Owner